1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Ophthalmic Imaging Equipment - Medical Devices Pipeline Assessment, 2016

Ophthalmic Imaging Equipment - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, “Ophthalmic Imaging Equipment - Medical Devices Pipeline Assessment, 2016" provides an overview of Ophthalmic Imaging Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ophthalmic Imaging Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Ophthalmic Imaging Equipment under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Ophthalmic Imaging Equipment and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Ophthalmic Imaging Equipment under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Ophthalmic Imaging Equipment - Medical Devices Pipeline Assessment, 2016
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Introduction 10
2.1 Ophthalmic Imaging Equipment Overview 10
3 Products under Development 11
3.1 Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development 11
3.2 Ophthalmic Imaging Equipment - Pipeline Products by Segment 12
3.3 Ophthalmic Imaging Equipment - Pipeline Products by Territory 13
3.4 Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path 14
3.5 Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date 15
3.6 Ophthalmic Imaging Equipment - Ongoing Clinical Trials 16
4 Ophthalmic Imaging Equipment - Pipeline Products under Development by Companies 17
4.1 Ophthalmic Imaging Equipment Companies - Pipeline Products by Stage of Development 17
4.2 Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development 19
5 Ophthalmic Imaging Equipment Companies and Product Overview 21
5.1 Aeon Imaging, LLC Company Overview 21
5.1.1 Aeon Imaging, LLC Pipeline Products and Ongoing Clinical Trials Overview 21
5.2 Aeon Scientific AG Company Overview 22
5.2.1 Aeon Scientific AG Pipeline Products and Ongoing Clinical Trials Overview 22
5.3 ArcScan, Inc. Company Overview 23
5.3.1 ArcScan, Inc. Pipeline Products and Ongoing Clinical Trials Overview 23
5.4 Ben-Gurion University of the Negev Company Overview 26
5.4.1 Ben-Gurion University of the Negev Pipeline Products and Ongoing Clinical Trials Overview 26
5.5 Brien Holden Vision Institute Company Overview 27
5.5.1 Brien Holden Vision Institute Pipeline Products and Ongoing Clinical Trials Overview 27
5.6 CW Optics, Inc. Company Overview 28
5.6.1 CW Optics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 28
5.7 Dalhousie University Company Overview 29
5.7.1 Dalhousie University Pipeline Products and Ongoing Clinical Trials Overview 29
5.8 Exploit Technologies Pte Ltd Company Overview 30
5.8.1 Exploit Technologies Pte Ltd Pipeline Products and Ongoing Clinical Trials Overview 30
5.9 Eye Marker Systems, Inc. Company Overview 31
5.9.1 Eye Marker Systems, Inc. Pipeline Products and Ongoing Clinical Trials Overview 31
5.10 Eye Tech Care SA Company Overview 32
5.10.1 Eye Tech Care SA Pipeline Products and Ongoing Clinical Trials Overview 32
5.11 Gemss Co.,Ltd. Company Overview 35
5.11.1 Gemss Co.,Ltd. Pipeline Products and Ongoing Clinical Trials Overview 35
5.12 George Washington University Company Overview 36
5.12.1 George Washington University Pipeline Products and Ongoing Clinical Trials Overview 36
5.13 Massachusetts Eye and Ear Infirmary Company Overview 37
5.13.1 Massachusetts Eye and Ear Infirmary Pipeline Products and Ongoing Clinical Trials Overview 37
5.14 Moorfields Eye Hospital NHS Foundation Trust Company Overview 38
5.14.1 Moorfields Eye Hospital NHS Foundation Trust Pipeline Products and Ongoing Clinical Trials Overview 38
5.15 Next Dimension Ltd. Company Overview 41
5.15.1 Next Dimension Ltd. Pipeline Products and Ongoing Clinical Trials Overview 41
5.16 OcuSciences, Inc. Company Overview 42
5.16.1 OcuSciences, Inc. Pipeline Products and Ongoing Clinical Trials Overview 42
5.17 Ocutronics, LLC Company Overview 43
5.17.1 Ocutronics, LLC Pipeline Products and Ongoing Clinical Trials Overview 43
5.18 Ohio State University Company Overview 44
5.18.1 Ohio State University Pipeline Products and Ongoing Clinical Trials Overview 44
5.19 Optos Plc Company Overview 45
5.19.1 Optos Plc Pipeline Products and Ongoing Clinical Trials Overview 45
5.20 PCAsso Diagnostics LLC Company Overview 50
5.20.1 PCAsso Diagnostics LLC Pipeline Products and Ongoing Clinical Trials Overview 50
5.21 Praevium Research Inc. Company Overview 51
5.21.1 Praevium Research Inc. Pipeline Products and Ongoing Clinical Trials Overview 51
5.22 Predictek, Inc. Company Overview 52
5.22.1 Predictek, Inc. Pipeline Products and Ongoing Clinical Trials Overview 52
5.23 Rensselaer Polytechnic Institute Company Overview 53
5.23.1 Rensselaer Polytechnic Institute Pipeline Products and Ongoing Clinical Trials Overview 53
5.24 RetiVue, LLC Company Overview 54
5.24.1 RetiVue, LLC Pipeline Products and Ongoing Clinical Trials Overview 54
5.25 Ti-TaMed (PTY) LTD. Company Overview 55
5.25.1 Ti-TaMed (PTY) LTD. Pipeline Products and Ongoing Clinical Trials Overview 55
5.26 Tufts University Company Overview 56
5.26.1 Tufts University Pipeline Products and Ongoing Clinical Trials Overview 56
5.27 Universite de Montreal Company Overview 57
5.27.1 Universite de Montreal Pipeline Products and Ongoing Clinical Trials Overview 57
5.28 University College London Company Overview 59
5.28.1 University College London Pipeline Products and Ongoing Clinical Trials Overview 59
5.29 University of Arizona Company Overview 61
5.29.1 University of Arizona Pipeline Products and Ongoing Clinical Trials Overview 61
5.30 University of California, Los Angeles Company Overview 62
5.30.1 University of California, Los Angeles Pipeline Products and Ongoing Clinical Trials Overview 62
5.31 University of Colorado Company Overview 64
5.31.1 University of Colorado Pipeline Products and Ongoing Clinical Trials Overview 64
5.32 University of South Florida Company Overview 65
5.32.1 University of South Florida Pipeline Products and Ongoing Clinical Trials Overview 65
5.33 University of Valencia Company Overview 66
5.33.1 University of Valencia Pipeline Products and Ongoing Clinical Trials Overview 66
5.34 Vision Instruments Pty. Ltd. Company Overview 67
5.34.1 Vision Instruments Pty. Ltd. Pipeline Products and Ongoing Clinical Trials Overview 67
5.35 VisionQuest Biomedical, LLC Company Overview 68
5.35.1 VisionQuest Biomedical, LLC Pipeline Products and Ongoing Clinical Trials Overview 68
5.36 Visual Pathways, Inc. (Inactive) Company Overview 73
5.36.1 Visual Pathways, Inc. (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 73
6 Ophthalmic Imaging Equipment- Recent Developments 76
6.1 Nov 07, 2016: Molecular Partners Announces Management Change 76
6.2 Nov 02, 2016: NOVADAQ Reports Third Quarter 2016 Financial Results 76
6.3 Oct 27, 2016: Molecular Partners: Quarterly Management Statement For The Period Ending September 30, 2016 77
6.4 Oct 27, 2016: ContextVision Presents Q3 2016 Financial Report 79
6.5 Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer 80
6.6 Oct 11, 2016: DigiSight Technologies Showcases State-of-the-Art Paxos Scope Mobile Imaging Solution At AAO 2016 81
6.7 Sep 28, 2016: Hill-Rom Adding More Than 100 Jobs In Central New York 81
6.8 Sep 12, 2016: Canon U.S.A. to Display Eyecare Devices and Solutions at Vision Expo West 82
6.9 Sep 09, 2016: KKR Invests USD66 Million in AcuFocus 83
6.10 Sep 01, 2016: Molecular Partners reports unaudited half-year results for 2016: A period of continued progress for Molecular Partners 83
6.11 Aug 18, 2016: ContextVision presents Q2 2016 financial report 85
6.12 Aug 12, 2016: Carl Zeiss Meditec Grows in Ophthalmology and Microsurgery 86
6.13 Aug 08, 2016: TearScience Names Edward J. Holland, MD to Board of Directors 87
6.14 Aug 02, 2016: MCW Researchers Lead Imaging Study of Patients with Genetic Color Vision Disorder in Advance of AGTC Gene Therapy Clinical Trials 88
6.15 Jul 27, 2016: NOVADAQ Reports Second Quarter 2016 Financial Results 88
6.16 Jul 27, 2016: Carl Zeiss Meditec Recruits James V. Mazzo to Lead Its Newly Consolidated Ophthalmology Organization 89
6.17 Jul 20, 2016: Carl Zeiss Meditec announces change to Management Board 90
6.18 Jul 13, 2016: CoxHealth brings diabetic digital retinal imaging to its patients 90
6.19 Jul 06, 2016: Natus Medical Acquires RetCam Ophthalmic Imaging Systems from Clarity Medical Systems for USD10.6 Million 90
6.20 Jul 06, 2016: NOVADAQ Announces Appointment of Rick Mangat as President and CEO 90
6.21 Jun 24, 2016: AcuFocus Raises USD1.9 Million in Venture Financing 91
6.22 May 16, 2016: Escalon Medical Reports Third Quarter Fiscal 2016 Results 91
6.23 May 11, 2016: Carl Zeiss Meditec Records Revenue Growth of 8.6 Percent 92
6.24 May 11, 2016: Nephros Reports First Quarter 2016 Financial Results 93
6.25 May 05, 2016: TearScience Introduces LipiScan For Rapid High Definition Meibomian Imaging 94
6.26 May 02, 2016: Large UK National Health Services (NHS) Study Finds EyeArt Device To Be the Most Sensitive Automated Retinal Image Analysis Technology for Diabetic Retinopathy Screening 94
6.27 Apr 29, 2016: Bausch + Lomb Highlights Scientific and Clinical Research during the Association for Research in Vision and Ophthalmology Annual Meeting in Seattle, WA 95
6.28 Apr 28, 2016: Quarterly Management Statement For The Period Ending March 31, 2016 96
6.29 Apr 14, 2016: ArcScan receives CE Mark Approval for Its Insight 100 device enabling commercialization across Europe 98
6.30 Apr 13, 2016: Molecular Partners Raises USD31.7 Million in Private Placement of Shares 98
6.31 Apr 12, 2016: iSTAR Medical Raises USD11.4 Million in Series B Financing 99
6.32 Mar 22, 2016: Breakthrough Handheld Technology from Welch Allyn Makes Diabetic Retinopathy Screening Simple and Affordable for Primary Care Settings 99
6.33 Mar 17, 2016: AcuFocus Raises USD4 Million in Financing 99
6.34 Feb 29, 2016: Canon U.S.A. Showcases Solutions and Services that can Help Healthcare Providers Achieve a More Complete EHR Strategy at HIMSS 2016 100
6.35 Feb 16, 2016: Escalon Medical Reports Second Quarter Fiscal 2016 Results 101
6.36 Feb 04, 2016: Molecular Partners reports unaudited financial results for 2015 101
6.37 Jan 25, 2016: AstraZeneca partners with peers and academia to establish translational research fund 104
6.38 Jan 24, 2016: Fallas Family Vision of McDonough, Georgia, Adds OptoMap Retinal System for an Ultra-Wide View of the Retina During Eye Exams 105
6.39 Jan 15, 2016: Remidio Innovative Solutions Raises Funds in Series B Financing 106
6.40 Jan 11, 2016: Bausch + Lomb Announces 2016 Elite Vendor Relationship with Vision Source 106
6.41 Dec 10, 2015: Molecular Partners received a European Small and Mid-Cap Award 106
6.42 Dec 03, 2015: ArcScan Finalizes US Food and Drug Administration Submission for Its Insight 100 Ophthalmic Medical Device 107
7 Appendix 108
7.1 Methodology 108
7.2 About GlobalData 111
7.3 Contact Us 111
7.4 Disclaimer 111

1.1 List of Tables
Table 1: Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development 11
Table 2: Ophthalmic Imaging Equipment - Pipeline Products by Segment 12
Table 3: Ophthalmic Imaging Equipment - Pipeline Products by Territory 13
Table 4: Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path 14
Table 5: Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date 15
Table 6: Ophthalmic Imaging Equipment - Ongoing Clinical Trials 16
Table 7: Ophthalmic Imaging Equipment Companies - Pipeline Products by Stage of Development 17
Table 8: Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development 19
Table 9: Aeon Imaging, LLC Pipeline Products and Ongoing Clinical Trials Overview 21
Table 10: DLP - Cam - Product Status 21
Table 11: DLP - Cam - Product Description 21
Table 12: Aeon Scientific AG Pipeline Products and Ongoing Clinical Trials Overview 22
Table 13: OctoMag System - Product Status 22
Table 14: OctoMag System - Product Description 22
Table 15: ArcScan, Inc. Pipeline Products and Ongoing Clinical Trials Overview 23
Table 16: Artemis 3 - Product Status 23
Table 17: Artemis 3 - Product Description 23
Table 18: ArcScan, Inc. - Ongoing Clinical Trials Overview 24
Table 19: Artemis 3 - Early Detection of Keratoconus 25
Table 20: Ben-Gurion University of the Negev Pipeline Products and Ongoing Clinical Trials Overview 26
Table 21: Diagnostic Tool - Retinal Disorders - Product Status 26
Table 22: Diagnostic Tool - Retinal Disorders - Product Description 26
Table 23: Brien Holden Vision Institute Pipeline Products and Ongoing Clinical Trials Overview 27
Table 24: Advanced Retinal Imaging System - Product Status 27
Table 25: Advanced Retinal Imaging System - Product Description 27
Table 26: CW Optics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 28
Table 27: RetinalImager - Product Status 28
Table 28: RetinalImager - Product Description 28
Table 29: Dalhousie University Pipeline Products and Ongoing Clinical Trials Overview 29
Table 30: Eye Imaging Device - Product Status 29
Table 31: Eye Imaging Device - Product Description 29
Table 32: Exploit Technologies Pte Ltd Pipeline Products and Ongoing Clinical Trials Overview 30
Table 33: Ocular Surface Disease Diagnostic System - Product Status 30
Table 34: Ocular Surface Disease Diagnostic System - Product Description 30
Table 35: Eye Marker Systems, Inc. Pipeline Products and Ongoing Clinical Trials Overview 31
Table 36: RTD 1000 - Product Status 31
Table 37: RTD 1000 - Product Description 31
Table 38: Eye Tech Care SA Pipeline Products and Ongoing Clinical Trials Overview 32
Table 39: EyeOP1 - Product Status 32
Table 40: EyeOP1 - Product Description 32
Table 41: Eye Tech Care SA - Ongoing Clinical Trials Overview 33
Table 42: EyeOP1 - EYEOP1, A Minimally-invasive, Single Use Ultrasound System Intended To Treat Refractory Glaucoma 34
Table 43: EyeOP1 - EYEOP1, A Minimally-invasive, Single Use Ultrasound System Intended To Treat Refractory Glaucoma 34
Table 44: EyeOP1 - Glaucoma Treatment Using Focused Ultrasound in Open Angle Glaucoma Patients 34
Table 45: Gemss Co.,Ltd. Pipeline Products and Ongoing Clinical Trials Overview 35
Table 46: Motorized C-arm System - Product Status 35
Table 47: Motorized C-arm System - Product Description 35
Table 48: George Washington University Pipeline Products and Ongoing Clinical Trials Overview 36
Table 49: iEye - Product Status 36
Table 50: iEye - Product Description 36
Table 51: Massachusetts Eye and Ear Infirmary Pipeline Products and Ongoing Clinical Trials Overview 37
Table 52: Portable Mydriatic Cameras - Product Status 37
Table 53: Portable Mydriatic Cameras - Product Description 37
Table 54: Moorfields Eye Hospital NHS Foundation Trust Pipeline Products and Ongoing Clinical Trials Overview 38
Table 55: Binocular Optical Coherence Tomography - Product Status 38
Table 56: Binocular Optical Coherence Tomography - Product Description 38
Table 57: Moorfields Eye Hospital NHS Foundation Trust - Ongoing Clinical Trials Overview 39
Table 58: Binocular Optical Coherence Tomography - A Prospective Single-Site Non-Interventional Study to Evaluate Human Factors and Usability of Automated, Comprehensive Ocular Examination in Elderly and Visually Impaired Populations Using a Prototype Binocular Optical Coherence Tomography System 40
Table 59: Next Dimension Ltd. Pipeline Products and Ongoing Clinical Trials Overview 41
Table 60: Retinal Spectral Imaging System - Product Status 41
Table 61: Retinal Spectral Imaging System - Product Description 41
Table 62: OcuSciences, Inc. Pipeline Products and Ongoing Clinical Trials Overview 42
Table 63: OcuMet Beacon - Product Status 42
Table 64: OcuMet Beacon - Product Description 42
Table 65: Ocutronics, LLC Pipeline Products and Ongoing Clinical Trials Overview 43
Table 66: Ocutronics OC-100 Retinal Camera - Product Status 43
Table 67: Ocutronics OC-100 Retinal Camera - Product Description 43
Table 68: Ohio State University Pipeline Products and Ongoing Clinical Trials Overview 44
Table 69: Interferometric Imaging System - Product Status 44
Table 70: Interferometric Imaging System - Product Description 44
Table 71: Optos Plc Pipeline Products and Ongoing Clinical Trials Overview 45
Table 72: 200TX Replacement Device - Product Status 45
Table 73: 200TX Replacement Device - Product Description 46
Table 74: CHARLOTTE - Product Status 46
Table 75: CHARLOTTE - Product Description 46
Table 76: INDIANAPOLIS - Product Status 47
Table 77: INDIANAPOLIS - Product Description 47
Table 78: Optos Plc - Ongoing Clinical Trials Overview 48
Table 79: 200TX Replacement Device - A Randomized Trial of Non-mydriatic Ultra-widefield Retinal Imaging to Screen for Diabetic Eye Disease: CLEAR SIGHT 49
Table 80: PCAsso Diagnostics LLC Pipeline Products and Ongoing Clinical Trials Overview 50
Table 81: PolyChromatic Angiography Device - Product Status 50
Table 82: PolyChromatic Angiography Device - Product Description 50
Table 83: Praevium Research Inc. Pipeline Products and Ongoing Clinical Trials Overview 51
Table 84: VCSEL Based OCT System - Product Status 51
Table 85: VCSEL Based OCT System - Product Description 51
Table 86: Predictek, Inc. Pipeline Products and Ongoing Clinical Trials Overview 52
Table 87: IRis - Product Status 52
Table 88: IRis - Product Description 52
Table 89: Rensselaer Polytechnic Institute Pipeline Products and Ongoing Clinical Trials Overview 53
Table 90: Video Scheimpflug Camera - Product Status 53
Table 91: Video Scheimpflug Camera - Product Description 53
Table 92: RetiVue, LLC Pipeline Products and Ongoing Clinical Trials Overview 54
Table 93: CAVCAM - Product Status 54
Table 94: CAVCAM - Product Description 54
Table 95: Ti-TaMed (PTY) LTD. Pipeline Products and Ongoing Clinical Trials Overview 55
Table 96: Optical Device - Product Status 55
Table 97: Optical Device - Product Description 55
Table 98: Tufts University Pipeline Products and Ongoing Clinical Trials Overview 56
Table 99: Digital Single Lens Reflex Adaptor - Product Status 56
Table 100: Digital Single Lens Reflex Adaptor - Product Description 56
Table 101: Universite de Montreal Pipeline Products and Ongoing Clinical Trials Overview 57
Table 102: Diagnostic Software - Ocular Rigidity - Product Status 57
Table 103: Diagnostic Software - Ocular Rigidity - Product Description 58
Table 104: University College London Pipeline Products and Ongoing Clinical Trials Overview 59
Table 105: Ocular Imaging System - Product Status 59
Table 106: Ocular Imaging System - Product Description 60
Table 107: University of Arizona Pipeline Products and Ongoing Clinical Trials Overview 61
Table 108: Retinal Illumination System - Product Status 61
Table 109: Retinal Illumination System - Product Description 61
Table 110: University of California, Los Angeles Pipeline Products and Ongoing Clinical Trials Overview 62
Table 111: Corneal Hydration Sensing System - Product Status 62
Table 112: Corneal Hydration Sensing System - Product Description 63
Table 113: University of Colorado Pipeline Products and Ongoing Clinical Trials Overview 64
Table 114: Multi-Photon Optics Device - Product Status 64
Table 115: Multi-Photon Optics Device - Product Description 64
Table 116: University of South Florida Pipeline Products and Ongoing Clinical Trials Overview 65
Table 117: Adaptive Optics Ophthalmic Imager - Product Status 65
Table 118: Adaptive Optics Ophthalmic Imager - Product Description 65
Table 119: University of Valencia Pipeline Products and Ongoing Clinical Trials Overview 66
Table 120: 3D Imaging Retinal Camera - Product Status 66
Table 121: 3D Imaging Retinal Camera - Product Description 66
Table 122: Vision Instruments Pty. Ltd. Pipeline Products and Ongoing Clinical Trials Overview 67
Table 123: ViNM1 Retinal Camera - Product Status 67
Table 124: ViNM1 Retinal Camera - Product Description 67
Table 125: VisionQuest Biomedical, LLC Pipeline Products and Ongoing Clinical Trials Overview 68
Table 126: DR-RACS - Product Status 68
Table 127: DR-RACS - Product Description 69
Table 128: Functional Scanning Laser Ophthalmoscope - Product Status 69
Table 129: Functional Scanning Laser Ophthalmoscope - Product Description 70
Table 130: VisionQuest Biomedical, LLC - Ongoing Clinical Trials Overview 71
Table 131: DR-RACS - Phase 0 Observational Study of a Computer-based Screening Algorithm for Detection of Diabetic Retinopathy 72
Table 132: Visual Pathways, Inc. (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 73
Table 133: Aris HySpect - Product Status 73
Table 134: Aris HySpect - Product Description 73
Table 135: Aris Pixie - Product Status 74
Table 136: Aris Pixie - Product Description 74
Table 137: ArisWareEP-3D - Product Status 74
Table 138: ArisWareEP-3D - Product Description 75
Table 139: Glossary 109

1.2 List of Figures
Figure 1: Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development 11
Figure 2: Ophthalmic Imaging Equipment - Pipeline Products by Segment 12
Figure 3: Ophthalmic Imaging Equipment - Pipeline Products by Territory 13
Figure 4: Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path 14
Figure 5: Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date 15
Figure 6: Ophthalmic Imaging Equipment - Ongoing Clinical Trials 16

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.